← Back to Search

MobiMD for Perioperative Care

N/A
Waitlist Available
Led By Corrine I Voils, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 180 days postoperative
Awards & highlights

Study Summary

This study is evaluating whether a mobile app can help patients recover from surgery.

Eligible Conditions
  • Readmissions
  • Perioperative Care

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~180 days postoperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and 180 days postoperative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of participants readmitted within 30 days of surgery
Secondary outcome measures
30 day postoperative complication severity as measured by Clavien-Dindo Score
90 day postoperative complication severity as measured by Clavien-Dindo Score
Proportion of participants readmitted within 90 days of surgery
+3 more
Other outcome measures
180-day pain intensity as measured by Patient-Reported Outcomes Measurement Information System (PROMIS) short form pain intensity scale
180-day participant satisfaction measured by Consumer Assessment of Healthcare Providers and Systems (CAHPS) Surgical Care Survey
180-day physical function as measured by Patient-Reported Outcomes Measurement Information System (PROMIS) short form score
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention - MobiMD appExperimental Treatment1 Intervention
Intervention group will receive notifications to their smart device through MobiMD app. Participants will be asked to fill out reports and upload all clinically relevant data using the app. Engaging with the app will be in addition to the standard of care follow-up.
Group II: Standard of CareActive Control1 Intervention
The standard of care control group will receive conventional postoperative care. Participants will receive reported outcome survey by email.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MobiMD
2020
N/A
~300

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,182 Previous Clinical Trials
3,167,087 Total Patients Enrolled
Corrine I Voils, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison
2 Previous Clinical Trials
922 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~67 spots leftby Apr 2025